AKORN FDA Approval ANDA 208872

ANDA 208872

AKORN

FDA Drug Application

Application #208872

Application Sponsors

ANDA 208872AKORN

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTION0.4MG/ML0NALOXONE HYDROCHLORIDENALOXONE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2017-03-14STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

AKORN
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 208872
            [companyName] => AKORN
            [docInserts] => ["",""]
            [products] => [{"drugName":"NALOXONE HYDROCHLORIDE","activeIngredients":"NALOXONE HYDROCHLORIDE","strength":"0.4MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"03\/14\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-03-14
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.